Fennec Pharmaceuticals Inc. is a biotechnology company focused on developing treatments for cancer survivors who experience hearing loss as a side effect of chemotherapy. The company aims to improve the quality of life for these patients through its specialized products. Fennec operates primarily in the healthcare sector, targeting oncology patients and healthcare providers.
